tumor tissues
SMMC7721
cell line-derived xenograft
Wnt/beta-catenin (promotes); proliferation (promotes); cell cycle (promotes); angiogenesis (promotes); radioresistance (promotes); mRNA stability (other)
RT-qPCR; Transfection; CCK8; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Tube Formation Assay; Western Blot; Colony Formation Assay; IF (Immunofluorescence); RIP (RNA Immunoprecipitation); RNA Pull-Down; Nuclear-Cytoplasmic Fractionation; FISH / smFISH; In Vivo Animal Model; IHC (Immunohistochemistry); TUNEL
cZNF292 may provide a valuable target for radiation therapy for hepatoma.
In hypoxic human hepatoma SMMC7721 cells, cZNF292 is induced and acts as a pro-tumor circRNA that supports proliferation, vasculogenic mimicry and radioresistance. Mechanistically, cytoplasmic cZNF292 binds SOX9, limits SOX9 nuclear translocation, and activates Wnt/beta-catenin signaling; cZNF292 knockdown suppresses these effects and improves radiosensitivity in vitro and in xenograft models.
0.723
Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance.
biological research